NOS3 and Hepatic fibrosis: Resisting angiogenesis in hepatic fibrosis through the PDGFRB/ERK/HIF-1α and VEGFA/AKT/eNOS signaling pathways may serve as a promising therapeutic approach for treating hepatic fibrosis.